Letter: extending FIT from DG30 to NG12 patients. Letter: faecal immunochemical testing for adults with symptoms of colorectal cancer - ready for prime time? Authors' reply: a unified approach to safety netting negative FITs is required.
Brian David NicholsonJames Edward EastJason OkeNia Wyn RobertsTim JamesBrian ShinePublished in: Alimentary pharmacology & therapeutics (2020)